ArticleScientific reports2025
Triplet offline causal discovery based on optimal Markov blanket and its application.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Offline constraint-based causal feature selection (OC-CFS) algorithms are essential for identifying causal relationships from observational data. However, existing methods often suffer from limitations such as low prediction accuracy or high computational cost, particularly when sample sizes vary. To address these limitations, we propose Triplet, a novel framework that leverages the HITON-MB Parents and Children (PC) strategy to identify strongly relevant PC nodes while eliminating irrelevant and redundant features. It concurrently employs the BAMB strategy to detect relevant spouses and discard irrelevant ones, and applies the STMB non-Markov Blanket (non-MB) strategy to identify and exclude non-MB descendants. Through this integration, the proposed T-OCD[Formula: see text] overcomes these limitations, accurately identifying the true MB with high prediction accuracy and reduced runtime. To validate its effectiveness, we evaluated T-OCD[Formula: see text] on benchmark Bayesian networks (BNs) and real-world datasets. Extensive experimental results demonstrate that T-OCD[Formula: see text] achieves significant improvements in both prediction accuracy and computational efficiency compared to existing methods. On small sample sizes (n=500), T-OCD[Formula: see text] achieved the highest recall in 5 out of 7 datasets, with an average improvement of over 20% compared to rivals. On large sample sizes (n=5000), it excelled in precision, achieving the top score in 4 out of 7 datasets with an average precision of 94%. Computationally, T-OCD[Formula: see text] is highly efficient, operating as the second-fastest method overall. It ran over 55% faster than half of the benchmarks and a remarkable 35% faster than the average competitor on large datasets. The source code for this research is available at the following repository: https://github.com/vickykhan89/T-OCDmb.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.